Company Filing History:
3 out of 13 
3 out of 29 
Years Active: 2023-2026
Title: Heike Schoenherr: Innovator in FGFR Inhibition
Introduction
Heike Schoenherr is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of FGFR inhibitors. Her innovative work has the potential to impact the treatment of various disorders associated with FGFR signaling.
Latest Patents
Heike Schoenherr holds a patent for "FGFR inhibitors and methods of use thereof." This patent relates to novel compounds and pharmaceutical compositions designed to inhibit the activity of FGFR enzymes. The methods outlined in her patent aim to treat disorders linked to FGFR signaling, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Heike has worked with notable companies such as Relay Therapeutics, Inc. and D.E. Shaw Research, LLC. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Heike has collaborated with talented individuals, including Bakary-Barry Touré and Fabrizio Giordanetto. These partnerships have enriched her work and fostered an environment of innovation and creativity.
Conclusion
Heike Schoenherr's contributions to the field of FGFR inhibition exemplify her dedication to advancing pharmaceutical science. Her innovative patents and collaborations highlight her role as a key figure in the industry.